INGENIOUS

Recommendations for Clinical CYP2C19 Genotyping Allele Selection: A Report of the Association for Molecular Pathology.

V. Pratt, Andria L. Del Tredici, H. Hachad, et al.. (2018). The Journal of molecular diagnostics : JMD. Cited 181 times. https://doi.org/10.1016/j.jmoldx.2018.01.011

Characterization of 137 Genomic DNA Reference Materials for 28 Pharmacogenetic Genes: A GeT-RM Collaborative Project.

V. Pratt, R. E. Everts, P. Aggarwal, et al.. (2016). The Journal of molecular diagnostics : JMD. Cited 130 times. https://doi.org/10.1016/j.jmoldx.2015.08.005

Implementation of a pharmacogenomics consult service to support the INGENIOUS trial

MT Eadon, Z. Desta, KD Levy, et al.. (2016). Clinical Pharmacology & Therapeutics. Cited 58 times. https://doi.org/10.1002/cpt.347

Lessons Learned When Introducing Pharmacogenomic Panel Testing into Clinical Practice.

M. Rosenman, B. Decker, Kenneth D Levy, et al.. (2017). Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research. Cited 57 times. https://doi.org/10.1016/j.jval.2016.08.727

Prerequisites to Implementing a Pharmacogenomics Program in a Large Health‐Care System

Kenneth D Levy, Brian S. Decker, Janet S Carpenter, et al.. (2014). Clinical Pharmacology & Therapeutics. Cited 42 times. https://doi.org/10.1038/clpt.2014.101

Clinical and educational impact of pharmacogenomics testing: a case series from the INGENIOUS trial.

Rebecca C. Pierson, Brandon T. Gufford, Z. Desta, et al.. (2017). Pharmacogenomics. Cited 7 times. https://doi.org/10.2217/pgs-2017-0042

CYP2D6 and Endoxifen in Tamoxifen Therapy: A Tribute to David A. Flockhart

Todd C. Skaar, Z. Desta. (2018). Clinical Pharmacology & Therapeutics. Cited 6 times. https://doi.org/10.1002/cpt.1039

CYP2D6 and Endoxifen in Tamoxifen Therapy: A Tribute to David A. Flockhart

Todd C. Skaar, Z. Desta. (2018). Clinical Pharmacology & Therapeutics. Cited 6 times. https://doi.org/10.1002/cpt.1039

FDA's draft guidance on laboratory‐developed tests increases clinical and economic risk to adoption of pharmacogenetic testing

Kenneth D Levy, V. Pratt, Todd C. Skaar, et al.. (2015). The Journal of Clinical Pharmacology. Cited 6 times. https://doi.org/10.1002/jcph.492

Report of new haplotype for ABCC2 gene: rs17222723 and rs8187718 in cis.

V. Pratt, B. N. Beyer, Daniel L. Koller, et al.. (2015). The Journal of molecular diagnostics : JMD. Cited 4 times. https://doi.org/10.1016/j.jmoldx.2014.11.005